Federal Register / Vol. 80, No. 38 / Thursday, February 26, 2015 / Notices 10495 

burden of the collection of information 

on those who are to respond, including 

the use of appropriate automated, 

electronic, mechanical, or other 

technological collection techniques or 

other forms of information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the: Office 

of Management and Budget, Office of 

Regulatory Affairs, OIRA_submission@

omb.eop.gov or by fax to 202–395–6974, 

Attention: NIH Desk Officer. 

DATES: Comment due date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 7 days of the date of 

this publication. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact Dr. Diane Post, 

Program Officer, Respiratory Diseases 

Branch, NIAID, NIH 5601 Fishers Lane, 

Bethesda, MD or call non-toll-free 

number at 240–627–3348 or email your 

request, including your address to: 

postd@niaid.nih.gov 

SUPPLEMENTARY INFORMATION: 

Proposed Collection: Human 

Influenza Surveillance of Health Care 

Centers in the United States and 

Taiwan, (NIAID), 0925—NEW, National 

Institute of Allergy and Infectious 

Diseases (NIAID), National Institutes of 

Health (NIH). 

Need and Use of Information 

Collection: This study will identify 

individuals with influenza through 

focused surveillance in key regions of 

the United States and Taiwan, rapidly 

identify circulating influenza strains to 

identify those with pandemic potential 

and create an invaluable bank of human 

samples from patients with influenza to 

characterize the basis of severe 

disease—a critical knowledge gap 

impacting effectiveness of decisionmaking around patient care. The 2014– 

15 influenza season is unique because 

the dominant circulating strain is an 

H3N2 strain that is not sensitive to the 

immunity induced by the influenza 

vaccine formulation administered to the 

general public. Our study will provide 

insight into viral determinants that may 

be contributing to the severity of 

influenza and associated morbidity and 

mortality this season. Capturing samples 

from this influenza season is essential 

for understanding the public health 

implications the virus may have in the 

future, and discerning the reasons 

behind the severity of the disease it 

causes. 

OMB approval is requested for 6 

months. There are no costs to 

respondents other than their time. The 

total estimated annualized burden hours 

are 500. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total burden 

hours 

Patients ............................................................................................................ 500 2 30/60 500 

Dated: February 20, 2015. 

Dione Washington, 

Project Clearance Liaison, NIAID, NIH, 

NIAID, NIH. 

[FR Doc. 2015–04069 Filed 2–25–15; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Fellowships: Risk, Prevention, and Health 

Behavior Overflow. 

Date: March 18, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892, 

(Virtual Meeting). 

Contact Person: Lee S. Mann, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3224, 

MSC 7808, Bethesda, MD 20892, 301–435– 

0677, mannl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, Innate/

Adaptive Immunology and Vaccine 

Development. 

Date: March 19–20, 2015. 

Time: 8:30 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Washington/Rockville, 1750 

Rockville Pike, Rockville, MD 20852. 

Contact Person: Patrick K. Lai, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2215, 

MSC 7812, Bethesda, MD 20892, 301–435– 

1052, laip@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel, 

Fellowships: Risk, Prevention and Health 

Behavior. 

Date: March 23–24, 2015. 

Time: 8:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Martha M. Faraday, Ph.D., 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3110, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

3575, faradaym@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: February 20, 2015. 

Anna Snouffer, 

Deputy Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2015–03936 Filed 2–25–15; 8:45 am] 

BILLING CODE 4140–01–P 


rmajette on DSK2VPTVN1PROD with NOTICES